Free Trial

Pharma-Bio Serv Q4 2022 Earnings Report

Pharma-Bio Serv logo
$0.58 0.00 (0.00%)
As of 01/21/2025

Pharma-Bio Serv EPS Results

Actual EPS
$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Pharma-Bio Serv Revenue Results

Actual Revenue
$4.64 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Pharma-Bio Serv Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Pharma-Bio Serv Earnings Headlines

Pharma-Bio Serv (PBSV) Projected to Post Quarterly Earnings on Monday
Trump currency shock imminent
Trump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launched a $1.9 trillion move against the Fed. What comes next could have dramatic consequences.
PBSV Makes Progress on Improvements
Pharma-Bio Serv Inc PBSV
See More Pharma-Bio Serv Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pharma-Bio Serv? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pharma-Bio Serv and other key companies, straight to your email.

About Pharma-Bio Serv

Pharma-Bio Serv (OTCMKTS:PBSV) operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

View Pharma-Bio Serv Profile

More Earnings Resources from MarketBeat